Compare WBX & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WBX | DRIO |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | Spain | United States |
| Employees | 696 | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.4M | 60.6M |
| IPO Year | N/A | 2013 |
| Metric | WBX | DRIO |
|---|---|---|
| Price | $3.72 | $6.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $4.75 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 102.5K | 5.6K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | $18.10 | $20.27 |
| Revenue Next Year | $94.11 | $47.58 |
| P/E Ratio | ★ N/A | $5.54 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $0.29 | $0.38 |
| 52 Week High | $7.83 | $17.74 |
| Indicator | WBX | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 65.92 | 35.04 |
| Support Level | $3.70 | $6.16 |
| Resistance Level | $3.97 | $9.46 |
| Average True Range (ATR) | 0.33 | 0.37 |
| MACD | 0.10 | -0.05 |
| Stochastic Oscillator | 80.69 | 3.00 |
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.